These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 184412)

  • 1. Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin.
    Calder IC; Goss DE; Williams PJ; Funder CC; Green CR; Ham KN; Tange JD
    Pathology; 1976 Jan; 8(1):1-6. PubMed ID: 184412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-hydroxyphenacetin, a new urinary metabolite of phenacetin in the rat.
    McLean S; Davies NW; Watson H; Favretto WA; Bignall JC
    Drug Metab Dispos; 1981; 9(3):255-60. PubMed ID: 6113936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine.
    Camus AM; Friesen M; Croisy A; Bartsch H
    Cancer Res; 1982 Aug; 42(8):3201-8. PubMed ID: 7046920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of N-hydroxyphenacetin in vitro and in vivo.
    Fischbach T; Lenk W
    Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of renal pelvic carcinoma by phenacetin in hydronephrosis-bearing rats of the SD/cShi strain.
    Murai T; Mori S; Machino S; Hosono M; Takeuchi Y; Ohara T; Makino S; Takeda R; Hayashi Y; Iwata H
    Cancer Res; 1993 Sep; 53(18):4218-23. PubMed ID: 8364917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of reactive metabolites of phenacetin in humans and rats.
    Veronese ME; McLean S; D'Souza CA; Davies NW
    Xenobiotica; 1985 Nov; 15(11):929-40. PubMed ID: 4082633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of species differences in N-hydroxyphenacetin mutagenicity: the role of deacetylation by rat and hamster liver microsomes.
    Nohmi T; Yoshikawa K; Ishidate M; Hiratsuka A; Watabe T
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4525-31. PubMed ID: 6398128
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of phenacetin and N-hydroxyphenacetin in isolated rat hepatocytes.
    McLean S
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):173-80. PubMed ID: 732893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation, and sulfate conjugation.
    Vaught JB; McGarvey PB; Lee MS; Garner CD; Wang CY; Linsmaier-Bednar EM; King CM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3424-9. PubMed ID: 7020926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA, RNA and protein synthesis and chromatin alteration by N-hydroxyphenacetin.
    Hayward NK; Lavin MF
    Xenobiotica; 1987 Jan; 17(1):115-24. PubMed ID: 2435067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and nephrotoxicity of phenacetin and sulfanilamide.
    Eyanagi R; Shigematsu H; Yoshida K; Yoshimura H
    J Pharmacobiodyn; 1985 Feb; 8(2):95-105. PubMed ID: 4009405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen).
    Johansson SL
    Int J Cancer; 1981; 27(4):521-9. PubMed ID: 7275356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man.
    Wirth PJ; Dybing E; von Bahr C; Thorgeirsson SS
    Mol Pharmacol; 1980 Jul; 18(1):117-27. PubMed ID: 6997726
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinogenicity of phenacetin: long-term feeding study in B6c3f1 mice.
    Nakanishi K; Kurata Y; Oshima M; Fukushima S; Ito N
    Int J Cancer; 1982 Apr; 29(4):439-44. PubMed ID: 7085132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive metabolites of phenacetin and acetaminophen: a review.
    Hinson JA
    Environ Health Perspect; 1983 Mar; 49():71-9. PubMed ID: 6339229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of N-acetyl-p-benzoquinone imine produced during the hydrolysis of the model phenacetin metabolite N-(pivaloyloxy)phenacetin.
    Novak M; Pelecanou M; Zemis JN
    J Med Chem; 1986 Aug; 29(8):1424-9. PubMed ID: 3735311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoma and renal tubule adenoma in rats fed aflatoxin and cyclopropenoid fatty acids.
    Lee DJ; Wales JH; Sinnhuber RO
    J Natl Cancer Inst; 1969 Nov; 43(5):1037-44. PubMed ID: 4311049
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of CYP1A2 in the toxicity of long-term phenacetin feeding in mice.
    Peters JM; Morishima H; Ward JM; Coakley CJ; Kimura S; Gonzalez FJ
    Toxicol Sci; 1999 Jul; 50(1):82-9. PubMed ID: 10445756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR.
    Wirth PJ; Alewood P; Calder I; Thorgeirsson SS
    Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.